AI Article Synopsis
- Sutureless aortic valve prostheses have become valuable tools for cardiothoracic surgeons due to their improved hemodynamic performance and ability to support minimally invasive surgeries.
- A study reviewed data from 200 patients who underwent sutureless aortic valve replacement, with findings indicating a moderate-risk patient profile and various surgical procedures performed, including isolated, combined CABG, and multivalve surgeries.
- Results showed low mortality rates at multiple follow-up points and no instances of paravalvular leakage, suggesting that sutureless valves are a safe and effective option with stable hemodynamic outcomes.
Article Abstract
Introduction: Due to their favourable hemodynamic performance and the ability to enable minimally invasive access procedures, sutureless aortic valve prostheses have found their place in the armamentarium of cardiothoracic surgeons. In this study, we sought to review our institutional experience of sutureless aortic valve replacement (SU-AVR).
Methods: We carried out a retrospective analysis of 200 consecutive patients who underwent an SU-AVR with a Perceval valve between December 2019 and February 2023.
Results: The mean age of patients was 69.3 ± 8.1 years, and patients showed a moderate-risk profile with a mean logistic EuroSCORE-II of 5.2 ± 8.1%. An isolated SU-AVR was performed in 85 (42.5%) patients, concomitant CABG was performed in 75 (37.5%) and 40 patients (20%) underwent a multivalve procedure involving SU-AVR. The cardiopulmonary bypass (CPB) and cross-clamp (CC) times were 82.1 ± 35.1 and 55.5 ± 27.8 min, respectively. In-hospital, 30-day, 6-month and 1-year mortality rates were 4.5%, 6.5%, 7.5% and 8.2%, respectively. The postoperative transvalvular mean pressure gradient was 6.3 ± 1.6 mmHg and stayed stable over the follow-up time. We reported no cases of paravalvular leakage, and the incidence of stroke was 0.5%.
Conclusions: With their favourable hemodynamic performance and shorter CC and CPB times, sutureless aortic valve prostheses facilitate minimally invasive access surgery, being a safe and durable promising approach for the surgical AVR.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299320 | PMC |
| http://dx.doi.org/10.3390/jcm12124163 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comparison of Sutureless and Sutured Aortic Valve Replacements in Patients with Redo Infective Endocarditis.
Medicina (Kaunas)
December 2024
Department of Cardiovascular Surgery, Heart Center, Cebeci Hospitals, Ankara University School of Medicine, 06230 Ankara, Turkey.
: This study aims to assess the postoperative outcomes and complications of sutureless and sutured aortic valve replacement in patients with infective endocarditis. : A total of 58 patients who underwent redo aortic valve replacement for bacterial or non-bacterial endocarditis between January 2018 and March 2023 were included in our study. Surgical procedures were performed through a full median sternotomy due to redo cases and to provide optimal access.
View Article and Find Full Text PDFImplantation of a sutureless aortic valve into the ring of a mechanical valve: an extreme solution for extreme cases.
Interdiscip Cardiovasc Thorac Surg
December 2024
Clinical Department for Cardiac Surgery, University Medical Centre Maribor, Maribor, Slovenia.
Reoperations due to dysfunction of artificial mechanical aortic valves represent a complex and high-risk surgical procedure, particularly for elderly patients. In this report, we present a case of an 81-year-old female patient where, due to structural degeneration of the mechanical valve, an emergency surgical procedure was indicated. After the removal of the valve leaflets, a sutureless aortic valve was implanted within the mechanical ring.
View Article and Find Full Text PDFComparison of Sutureless Aortic Valve Replacement and Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis of Propensity Score Matching.
Rev Cardiovasc Med
November 2024
The First Clinical Medical College of Lanzhou University, 730000 Lanzhou, Gansu, China.
Background: To evaluate the clinical outcomes of sutureless aortic valve replacement (SUAVR) and transcatheter aortic valve implantation (TAVI).
Methods: We systematically searched the electronic database and the Clinical Trials Registry up to 31 February 2023. Random effects model risk ratio () and mean differences (MD) with corresponding 95% confidence intervals (CIs) were pooled for the clinical outcomes.
Sutureless Bioprostheses for Aortic Valve Replacement: An Updated Systematic Review with Long-Term Results.
J Clin Med
November 2024
Cardiovascular Research Institute, CARIM, 6629 ER Maastricht, The Netherlands.
Article Synopsis
- Aortic valve replacement (AVR) has seen an increased use of the Perceval sutureless bioprosthesis, which shows promising safety and reliability in both short- and mid-term outcomes, with some long-term data emerging.
- An updated systematic review of studies from 2015 to 2024 analyzed long-term outcomes of 5,221 patients with Perceval implants, revealing a long-term survival rate between 64.8% to 87.9% and low rates of complications such as structural valve degeneration and significant leaks.
- Despite limited data on sutureless bioprostheses, the encouraging results from existing studies suggest that Perceval could provide
Right anterior thoracotomy vs. upper hemisternotomy for aortic valve replacement with Perceval S: is there a difference?
Front Cardiovasc Med
October 2024
Cardiac Surgeon, Clinic for Cardiac Surgery, Dedinje Cardiovascular Institute, Belgrade, Serbia.
Background: Our study aimed to evaluate the early outcomes of aortic valve replacement with Perceval S sutureless valve through the right anterior thoracotomy and upper hemisternotomy approaches, and to determine if there are any differences between these two approaches.
Methods: We carried out a study using data from 174 patients who underwent minimally invasive Perceval S valve implantation for aortic valve stenosis between January 2018 and August 2023. This was a retrospective, single-center observational study.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!